Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Assessing the pros and cons of zero based budgeting can guide your financial planning. Discover what works best for your situation.
28,655 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
SpaceX stock has shown high enthusiasm but also sharp swings. Understanding a catalyst that could cause a drop helps ...
Global markets can offer growth outside the U.S. In this guide, we break down why international stocks may outperform...
Bitcoin slid toward the $58,000 level as Strategy's STRC dropped to fresh lows and MSTR followed lower. This article ...
March 2026 sees renewed volatility in energy and metals markets, prompting traders to reevaluate their platforms. Thi...
Investors are watching canopy growth's medical marijuana as a potential engine for a rebound. This guide breaks down ...
Gold Exposure through the SPDR Gold ETF can anchor a diversified portfolio. This article explains why SPDR Gold Been ...
A stock delivering a 7% dividend yield and yet slipping 20% year-to-date may seem puzzling. This guide explains how t...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Centene's Sarah London, the youngest-ever female Fortune 500 CEO, is steering a bold reinvention of the nation's larg...
If you’re weighing AI investing options, two popular ETFs—CHAT and XLK—show two very different paths. This guide brea...
A civil social-media debate this spring highlighted a looming fight over who will own payments: Visa or on-chain stab...